As per media reports, the company, backed by OrbiMed has filed its draft red herring prospectus with the capital markets regulator Sebi, outlining its intention to raise capital through an initial public offering (IPO)
Read MoreHDFC Pharma and Healthcare Fund aims to invest the core of the portfolio (> 80 per cent) in pharma and healthcare-related companies
Read MoreThe approval is for the acquisition of up to 76.1 per cent equity shares of Suven Pharmaceuticals, listed on the National Stock Exchange of India and the Bombay Stock Exchange by Berhyanda, Cyprus, by way of transfer of shares from existing promoter shareholders and public shareholders through a mandatory open offer
Read MoreMaxvision is aiming to invest Rs 400 crores in the coming three to four years while employing close to 2,000 people in Tamil Nadu
Read MoreThrough this investment, Siddhanta Medicity is poised to establish a network of hospitals across India
Read MoreJupiter Life Line Hospitals is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India with a total bed capacity of 1,194 hospital beds across three hospitals as of March 31, 2023
Read MoreThis fresh infusion of equity capital MediBuddy said will be used for growth and expansion through strategic acquisitions
Read MoreAccording to the fresh draft red herring prospectus (DRHP) filed on Friday, the initial public offering (IPO) is entirely an offer for sale of up to 2.8 crore equity shares of Medi Assist by promoters and existing shareholders.
Read More